Updates In Treating Pediatric Leukemias – For Nurses

  • This course closed on 12/20/2023.

Credit Available: NCPD

  • Enrollment in this course closed on 12/20/2023.

Activity Description

This activity will provide an overview of treating pediatric acute leukemia, including acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Faculty will focus on identifying signs and symptoms, diagnostic tests, treatments, including the importance of clinical trials, and highlight The Leukemia & Lymphoma Society’s PedAL trial, a precision medicine clinical trial for pediatric acute leukemia. Finally, faculty will discuss psychosocial and other survivorship challenges and how to overcome these, including resources for support.

This course is available from:

May 11, 2022 until December 20, 2023

Course Instructors

Todd M. Cooper, DO Speaker

Professor of Pediatrics/University of Washington Seattle Children’s Hospital, Seattle, WA

Kristina Lopez, LCSW, MSW Speaker

Information Specialist Information Resource Center The Leukemia & Lymphoma Society Rye Brook, NY

Target Audience

This CE activity is intended for oncologists, pediatric hematologist-oncologists, nurses, and oncology social workers involved in the care of patients with hematologic malignancies.

Educational Objectives

After completing this CE activity, the participant should be better able to:

  • Describe common childhood blood cancers, including AML and ALL
  • Identify signs and symptoms of childhood blood cancers and diagnostic tests
  • Explain treatments, including the role of clinical trials, and LLS PedAL, a precision medicine clinical trial for pediatric AML
  • Describe management of short- and long-term side effects of treatment, follow-up care plans, and communication between the pediatrician/family physician and oncologist
  • Describe psychosocial and survivorship challenges and resources to support children and their familie
Nursing Continuing Professional Development

Nursing LogoApproval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society National Office under Provider Number CEP 5832 to award 1.0 continuing education contact hours through the California Board of Registered Nursing.

Support Statement

There is no commercial support associated with this CE activity.

To view system requirements please go to https://llsce.org/system-requirements

For questions, grievances, or assistance with special needs (physical, etc.) please contact us at ProfEducation@LLS.org.

Disclosure of Conflicts of Interest Policy

Medical Learning Institute, Inc., is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, MLI requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to MLI policy. These disclosures will be provided to learners prior to the start of the CE activity.

Faculty Disclosures

Todd M. Cooper, DO

Professor of Pediatrics/University of Washington
Evans Family Endowed Chair in Pediatric Cancer
Section Chief – Pediatric Oncology
Director of the Pediatric Leukemia/Lymphoma Program
Co-Director of the High-Risk Leukemia Program
Seattle Children’s Hospital
Seattle, WA

Todd M. Cooper, DO, has no relevant financial relationship(s) with ineligible companies to disclose for this educational activity.

Kristina Lopez, LCSW, MSW

Information Specialist
Information Resource Center
The Leukemia & Lymphoma Society
Rye Brook, NY

Kristina Lopez, LCSW, MSW, has a financial interest/relationship or affiliation in the form of:
Advisor/Consultant: AYA ALL Access to Care

Caroline Kornhauser, MPH

Senior Manager
Professional Education
The Leukemia & Lymphoma Society
Rye Brook, NY

Caroline Kornhauser, MPH, has no relevant financial relationship(s) with ineligible companies to disclose for this educational activity.

All of the relevant financial relationships of individuals for this activity have been mitigated.

Planning Committee and Content/Peer Reviewers

The planners and content/peer reviewers from Medical Learning Institute, Inc., the accredited provider, and The Leukemia & Lymphoma Society, the joint provider do not have any relevant financial relationship(s) to disclose with ineligible companies unless listed below.

Lauren Berger, MPH

The Leukemia & Lymphoma Society
Rye Brook, NY

Lauren Berger, MPH, has a financial interest/relationship or affiliation in the form of:
Stock Ownership with Bristol Myers Squibb, Gilead Sciences, Inc., Merck & Co., Inc., Organon & Co., Pfizer Inc., and Viatris Inc.

All of the relevant financial relationships of individuals for this activity have been mitigated.

Disclosure of Unlabeled Use

This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities

Method of Participation

There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 70% or higher is needed to obtain credit.  Once submitted, the certificate will be automatically generated as a PDF online

For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

If you have questions regarding your certificate, please contact Nicole Dane via email at ndane@mlieducation.org.

You must be enrolled to complete this activity for credit, however, you are not required to enroll simply to view the presentation. 

Resources for You

  • FREE CME and CE courses for healthcare professionals: www.LLS.org/CE
  • Staying Connected: Facilitating the Learning Experience During and After Cancer Treatment, online CE program for school nurses, social workers, teachers and other school personnel. Focuses on medical, education & psychosocial support for children & AYAs treated for any type of cancer – www.LLS.org/StayingConnected
  • Treating Blood Cancers Podcast series for healthcare professionals: www.LLS.org/HCPpodcast. Experts discuss the latest developments in blood cancers, new and emerging treatment options, side-effect management, survivorship issues, and more. Pediatric and AYA topics include:
    • Wearing Two Hats: Supporting the Childhood Cancer Patient as Nurse & Parent
    • Long-Term & Late Effects of Childhood Cancer
    • Childhood Blood Cancers
    • Pediatric Survivorship
    • Facilitating the Learning Experience of Children and AYAs During and After Cancer Treatment
  • LLS Online Community: HCP, Patient/Survivor & Caregiver account types: www.LLS.org/community
    • Safe and secure site dedicated to research and has been created to support those living with blood cancer, their closest family members and healthcare professionals.
  • Information Resource Specialists: Nurses, social workers, and health educators who assist through treatment, financial, and social challenges. They offer up-to-date disease and treatment information – www.LLS.org/IRC
  • Clinical Trial Nurse Navigators: Registered Nurses with expertise in blood cancers personally assist through the clinical trial process with patients, caregivers or HCPs – www.LLS.org/navigation Or, refer your patient directly – www.LLS.org/CTSCreferral

Resources for Patients

  • Childhood blood cancer resources: www.LLS.org/Childhoodcancer
  • Follow-up care for childhood blood cancer survivorship: www.LLS.org/ChildhoodFollowUp
  • Telephone and web education programs: www.LLS.org/Programs and www.LLS.org/Educationvideos for patients and caregivers
  • Free booklets and fact sheets on disease, treatment and survivorship: www.LLS.org/Booklets
    • Examples include: Living and Learning with Cancer, Long-term and Late Effects of Leukemia & Lymphoma Facts, Young Adults and Cancer, Young Adult Journal, Fertility and Cancer, Pictures of My Journey
  • Support resources: www.LLS.org/Support
    • Financial assistance
      • Co-Pay
      • Travel Assistance
      • Referral to medication access programs
    • LLS regions
    • LLS Community (social media platform)
    • Online chats
    • Patti Robinson Kaufman First Connection Program (peer-to-peer)
    • One-On-One Nutrition Consultations (PearlPoint)
  • The LLS Children’s Initiative: Cures & Care for Children – LLS’ multi-year endeavor to attack pediatric blood cancer – research grants, education and support for children and their families, new policy and advocacy efforts – www.LLS.org/childrens-initiative
  • PedAL: Global precision medicine master clinical trial that will test multiple targeted therapies simultaneously at up to 200 clinical sites worldwide to treat children with relapsed acute leukemia, working in collaboration with NCI & COG – www.LLS.org/lls-childrens-initiative-pedal

If you have any questions, please contact us at ProfEducation@LLS.org or call our Information Resource staff at (800)-955-4572.

Scroll to Top